Replies to post #27368 on Amarin Corp Plc (AMRN)

[BioChica]

Kowa overlaps with about 70% of our target physicians. They extend the reach another approximately 30,000 physicians. So overall, we cover about 90% of the Lovaza prescriptions. Regarding the dynamics of uptake and why we're confident Kowa is the right partner is that frequency is a big player and our message plays very well when it's delivered on a regular basis for the right physicians. We do know there's a response to that frequency. We do know physicians respond well to the Vascepa message. What's good about Kowa and why this is such a fundamentally sound partnership is that they have, not only do they cover the physicians we need them to cover, but they have existing relationships and have been selling lipid agents vastatin and a fibrate which they'll now push back and bring Vascepa in as a priority to them. So we expect their uptake to happen rather quickly, of course, as John already characterized, it's still requires them to get to those physicians with a certain level of frequency and that will take some time over the second half of the year. But we're very confident and where we're going moving forward. When physicians -- as we get more experience, as physicians get more patient experience with Vascepa, we continue to hear positive feedback from their use. And given the feedback, we got on the Vascepa message and we see how frequency plays out as time goes on, we think we'll be very successful in accelerating the prescriptions here in the second half of the year.

From transcript!

[BioChica]

Our sales reps + Kowa reps have to meet this target, So we can all party!!! This table is based on RAW sales on $168 wsc.
w slight error between quarters.

 
 1/10/2014	2443	4006	6449	$1,083,432.00		} 
 1/17/2014	2485	3468	5953	$1,000,104.00		 
 1/24/2014	2683	3494	6177	$1,037,736.00		 
 1/31/2014	2641	3327	5968	$1,002,624.00		 
 2/7/2014	2659	3454	6113	$1,026,984.00		 
 2/14/2014	2918	3567	6485	$1,089,480.00		 
 2/21/2014	2786	3487	6273	$1,053,864.00		 
 2/28/2014	2940	3411	6351	$1,066,968.00		 
 3/7/2014	3170	3413	6583	$1,105,944.00		 
 3/14/2014	3102	3723	6825	$1,146,600.00		 
 3/21/2014	3055	3572	6627	$1,113,336.00		} 
 3/28/2014	3023	3583	6606	$1,109,808.00	$12,600,840.00 reported 11 Million	} 
 4/4/2014	3040	3609	6649	$1,117,032.00		} 
 4/11/2014	3127	3709	6836	$1,148,448.00		 
 4/18/2014	3164	3751	6915	$1,161,720.00		 
 4/25/2014	3145	3813	6958	$1,168,944.00		 
 5/2/2014	3360	4104	7464	$1,253,952.00		 
 5/9/2014			7970	$1,293,096.00		 
 5/16/2014			8476	$1,597,176.00		 
 5/23/2014			8982	$1,897,392.00		 
 5/30/2014			9488	$2,243,304.00		 
 6/6/2014			9994	$2,607,528.00		 
 6/13/2014			10500	$2,993,256.00		 
 6/20/2014			11006	$3,390,072.00		 
 6/27/2014			11512	$3,759,168.00		} 
 7/4/2014			12018	$4,136,496.00	$26,740,896.00	} 
 7/11/2014			12524	$4,502,400.00		}